The CentiMarker project: Standardizing quantitative Alzheimer’s disease fluid biomarkers for biologic interpretation.

15 April, 2025

Alzheimers Dement. 2025 Apr;21(4):e14587. doi: 10.1002/alz.14587. PMID: 40235082

Read the article

Characterizing visual read tau-PET-negative participants with Alzheimer’s disease dementia

Alzheimers Dement. 2025 Apr;21(4):e14423. doi: 10.1002/alz.14423. PMID: 40219781 Free PMC article.

Read the article

Associations between the EAT-Lancet planetary health diet and incident dementia.

12 April, 2025

J Prev Alzheimers Dis. 2025 Apr 12:100166. doi: 10.1016/j.tjpad.2025.100166. Online ahead of print.PMID: 40222839 Free article.

Read the article

Plasma phospho-tau217 for Alzheimer’s disease diagnosis in primary and secondary care using a fully automated platform

10 April, 2025

Nat Med. 2025 Apr 9. doi: 10.1038/s41591-025-03622-w. Online ahead of print. PMID: 40205199

Read the article

Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer’s disease

31 March, 2025

Nat Med. 2025 Mar 31. doi: 10.1038/s41591-025-03617-7. Online ahead of print. PMID: 40164726

Read the article

A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer’s disease.

Nat Med. 2025 Mar 31. doi: 10.1038/s41591-025-03565-2. Online ahead of print. PMID: 40164724

Read the article

Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials

28 March, 2025

Nat Aging. 2025 Mar 28. doi: 10.1038/s43587-025-00835-z. Online ahead of print. PMID: 40155777

Read the article

The impact of disease activity and interferon-α on the nervous system in systemic lupus erythematosus.

20 March, 2025

Arthritis Res Ther. 2025 Mar 20;27(1):60. doi: 10.1186/s13075-025-03539-2. PMID: 40114276 Free PMC article.

Read the article

Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer’s disease.

15 March, 2025

Alzheimers Dement. 2025 Mar;21(3):e14528. doi: 10.1002/alz.14528. PMID: 40042435 Free PMC article. Review.

Read the article

Concordance between the updated Elecsys cerebrospinal fluid immunoassays and amyloid positron emission tomography for Alzheimer’s disease assessment: findings from the Apollo study

13 March, 2025

Clin Chem Lab Med. 2025 Mar 13. doi: 10.1515/cclm-2024-1476. Online ahead of print. PMID: 40068924 Free article.

Read the article

Machine learning prediction of tau‐PET in Alzheimer’s disease using plasma, MRI, and clinical data

4 March, 2025

Alzheimers Dement. 2025 Feb 22;21(2):e14600. doi: 10.1002/alz.14600

Read the article

Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-Analysis.

3 March, 2025

JAMA Neurol. 2025 Mar 3;82(4):364-75. doi: 10.1001/jamaneurol.2025.0013. Online ahead of print. PMID: 40029638

Read the article

Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model mice.

2 March, 2025

Nat Aging. 2025 Mar;5(3):366-375. doi: 10.1038/s43587-025-00810-8. Epub 2025 Feb 12. PMID: 39939821 Free PMC article.

Read the article

Biofluid biomarkers in distinguishing young-onset dementia from primary psychiatric disorders

1 March, 2025

Curr Opin Psychiatry. 2025 Mar 1;38(2):134-143. doi: 10.1097/YCO.0000000000000979. Epub 2025 Jan 15. PMID: 39887317 Review.

Read the article

The Alzheimer’s Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study.

5 February, 2025

Alzheimers Dement. 2025 Feb;21(2):e14508. doi: 10.1002/alz.14508. Epub 2025 Feb 5. PMID: 39907496 Free PMC article.

Read the article

Toward a biological definition of neuronal and glial synucleinopathies.

1 February, 2025

Nat Med. 2025 Feb;31(2):396-408. doi: 10.1038/s41591-024-03469-7. Epub 2025 Jan 30. PMID: 39885358 Review.

Read the article

Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment.

29 January, 2025

Nat Commun. 2025 Jan 29;16(1):1139. doi: 10.1038/s41467-025-56293-z. PMID: 39881147 Free PMC article.

Read the article

Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer’s disease spectrum.

Brain. 2025 Jan 29:awaf033. doi: 10.1093/brain/awaf033. Online ahead of print. PMID: 39879633

Read the article

Blood Biomarkers to Detect Alzheimer Disease-Reply.

JAMA. 2025 Feb 18;333(7):634-635. doi: 10.1001/jama.2024.25297. PMID: 39847373 No abstract available.

Read the article

Expert opinions on pharmacological symptomatic treatment of behavioral symptoms in frontotemporal dementia: A survey of the Neuropsychiatric International Consortium on Frontotemporal Dementia (NIC-FTD)

16 January, 2025

Eur J Neurol. 2025 Jan;32(1):e16537. doi: 10.1111/ene.16537. Epub 2024 Nov 28. PMID: 39607834 Free PMC article.

Read the article

APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta.

Brain. 2025 Jan 16:awaf016. doi: 10.1093/brain/awaf016. Online ahead of print. PMID: 39817469

Read the article

Cutting through the noise: A narrative review of Alzheimer’s disease plasma biomarkers for routine clinical use

14 January, 2025

J Prev Alzheimers Dis. 2025 Apr;12(4):100056. doi: 10.1016/j.tjpad.2024.100056. Epub 2025 Jan 14. PMID: 39814656 Free article. Review.

Read the article

Point of view: Challenges in implementation of new immunotherapies for Alzheimer’s disease

10 January, 2025

J Prev Alzheimers Dis. 2025 Jan;12(1):100022. doi: 10.1016/j.tjpad.2024.100022. Epub 2025 Jan 1. PMID: 39800469 Free article.

Read the article

Amyloid-β and tau deposition in traumatic brain injury: a study of Vietnam War veterans

Brain Commun. 2025 Jan 10;7(1):fcaf009. doi: 10.1093/braincomms/fcaf009. eCollection 2025. PMID: 39845735 Free PMC article.

Read the article

evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease.

8 January, 2025

Alzheimers Res Ther. 2025 Jan 8;17(1):14. doi: 10.1186/s13195-024-01666-7. PMID: 39780249 Free PMC article. Clinical Trial.

Read the article

Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup.

J Nucl Med. 2025 Jan 8:jnumed.124.268756. doi: 10.2967/jnumed.124.268756. Online ahead of print. PMID: 39778970

Read the article

Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup.

Alzheimers Dement. 2025 Jan;21(1):e14338. doi: 10.1002/alz.14338. Epub 2025 Jan 8. PMID: 39776249 Free PMC article. Review.

Read the article

Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia.

6 January, 2025

Aust N Z J Psychiatry. 2025 Mar;59(3):248-259. doi: 10.1177/00048674241307906. Epub 2025 Jan 4. PMID: 39754499

Read the article

Benchmarking Alzheimer’s disease prediction: personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies.

Alzheimers Res Ther. 2025 Jan 6;17(1):6. doi: 10.1186/s13195-024-01664-9. PMID: 39762974 Free PMC article.

Read the article

Diffusion tensor imaging along the perivascular space: the bias from crossing fibres.

5 January, 2025

Brain Commun. 2024 Nov 21;6(6):fcae421. doi: 10.1093/braincomms/fcae421. eCollection 2024. PMID: 39713238 Free PMC article.

Read the article

Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum.

17 December, 2024

Brain. 2024 Dec 17:awae405. doi: 10.1093/brain/awae405. Online ahead of print. PMID: 39689039

Read the article

Plasma p-tau217 in Alzheimer’s disease: Lumipulse and ALZpath SIMOA head-to-head comparison.

16 December, 2024

Brain. 2024 Dec 16:awae368. doi: 10.1093/brain/awae368. Online ahead of print.PMID: 39679606

Read the article

Plasma neurofilament light outperforms glial fibrillary acidic protein in differentiating behavioural variant frontotemporal dementia from primary psychiatric disorders.

15 December, 2024

J Neurol Sci. 2024 Dec 15;467:123291. doi: 10.1016/j.jns.2024.123291. Epub 2024 Nov 8.PMID: 39577322 Free article.

Read the article

Balance and gait disorders in de novo Parkinson’s disease: support for early rehabilitation.

12 December, 2024

J Neurol. 2024 Dec 12;272(1):11. doi: 10.1007/s00415-024-12804-4.PMID: 39666175 Free PMC article.

Read the article

Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort.

J Neurol. 2024 Dec 12;272(1):25. doi: 10.1007/s00415-024-12732-3.PMID: 39666133

Read the article

Multiomics profiling of DNA methylation, microRNA, and mRNA in skeletal muscle from monozygotic twin pairs discordant for type 2 diabetes identifies dysregulated genes controlling metabolism.

2 December, 2024

BMC Med. 2024 Dec 2;22(1):572. doi: 10.1186/s12916-024-03789-y.PMID: 39623445 Free PMC article.

Read the article

Corticotropin-releasing hormone as a candidate biomarker for parkinsonian disorders.

19 November, 2024

Brain Commun. 2024 Nov 19;6(6):fcae414. doi: 10.1093/braincomms/fcae414. eCollection 2024.PMID: 39605973 Free PMC article.

Read the article

Free Recall Outperforms Story Recall in Associations with Plasma Biomarkers in Preclinical Alzheimer Disease.

15 November, 2024

J Prev Alzheimers Dis. 2024;11(6):1696-1702. doi: 10.14283/jpad.2024.130.PMID: 39559880 Free PMC article.

Read the article

GBA1 T369M and Parkinson’s disease – Further evidence of a lack of association in the Swedish population.

31 October, 2024

Parkinsonism Relat Disord. 2024 Oct 31;130:107191. doi: 10.1016/j.parkreldis.2024.107191. Online ahead of print.PMID: 39514913 Free article.

Read the article

A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests.

28 October, 2024

Brain. 2024 Oct 28:awae346. doi: 10.1093/brain/awae346. Online ahead of print.PMID: 39468767

Read the article

Individualized, cross-validated prediction of future dementia using cognitive assessments in people with mild cognitive symptoms.

25 October, 2024

Alzheimers Dement. 2024 Oct 17. doi: 10.1002/alz.14305. Online ahead of print. PMID: 39417379

Read the article

Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer’s disease: a pilot study

Sci Rep. 2024 Oct 25;14(1):25419. doi: 10.1038/s41598-024-75406-0.PMID: 39455624 Free PMC article.

Read the article

Biological mechanisms of resilience to tau pathology in Alzheimer’s disease.

12 October, 2024

Alzheimers Res Ther. 2024 Oct 12;16(1):221. doi: 10.1186/s13195-024-01591-9. PMID: 39396028 Free PMC article.

Read the article

Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer’s disease.

11 October, 2024

Med. 2024 Oct 11;5(10):1206-1226. doi: 10.1016/j.medj.2024.08.004. Epub 2024 Sep 9. PMID: 39255800 Free article. Review.

Read the article

Challenges in the practical implementation of blood biomarkers for Alzheimer’s disease

10 October, 2024

Lancet Healthy Longev. 2024 Oct;5(10):100630. doi: 10.1016/j.lanhl.2024.07.013. Epub 2024 Oct 3. PMID: 39369727 Free article. Review.

Read the article

Considerations for widespread implementation of blood-based biomarkers of Alzheimer’s disease.

6 October, 2024

Alzheimers Dement. 2024 Oct 6. doi: 10.1002/alz.14150. Online ahead of print. PMID: 39369283

Read the article

Recommendations for clinical implementation of blood-based biomarkers for Alzheimer’s disease.

1 October, 2024

Alzheimers Dement. 2024 Oct 1. doi: 10.1002/alz.14184. Online ahead of print. PMID: 39351838

Read the article

Dementia in Down syndrome

30 September, 2024

Lakartidningen. 2024 Sep 30;121:23083. PMID: 39354735 Free article. Swedish.

Read the article

Cerebrovascular disease is associated with Alzheimer’s plasma biomarker concentrations in adults with Down syndrome.

25 September, 2024

Brain Commun. 2024 Sep 25;6(5):fcae331. doi: 10.1093/braincomms/fcae331. eCollection 2024.

Read the article

A Statistical Framework for Assessing the Relationship between Biomarkers and Clinical Endpoints in Alzheimer’s Disease.

J Prev Alzheimers Dis. 2024;11(5):1228-1240. doi: 10.14283/jpad.2024.126. PMID: 39350368 Free PMC article. Review.

Read the article

Association of in vivo retention of [18f] flortaucipir pet with tau neuropathology in corresponding brain regions.

19 September, 2024

Acta Neuropathol. 2024 Sep 19;148(1):44. doi: 10.1007/s00401-024-02801-2. PMID: 39297933 Free PMC article.

Read the article

Integrating amyloid and tau imaging with proteomics and genomics in Alzheimer’s disease

17 September, 2024

Cell Rep Med. 2024 Sep 17;5(9):101735. doi: 10.1016/j.xcrm.2024.101735.

Read the article

Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease.

16 September, 2024

Alzheimers Res Ther. 2024 Sep 16;16(1):204. doi: 10.1186/s13195-024-01571-z. PMID: 39285454 Free PMC article.

Read the article

Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease.

14 September, 2024

Nat Commun. 2024 Sep 14;15(1):8061. doi: 10.1038/s41467-024-52299-1. PMID: 39277604 Free PMC article.

Read the article

Associations between misfolded alpha-synuclein aggregates and Alzheimer’s disease pathology in vivo.

11 September, 2024

Alzheimers Dement. 2024 Sep 11. doi: 10.1002/alz.14225. Online ahead of print. PMID: 39258841

Read the article

Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies.

26 August, 2024

Nat Neurosci. 2024 Oct;27(10):1880-1891. doi: 10.1038/s41593-024-01737-w. Epub 2024 Aug 26. PMID: 39187705 Free PMC article.

Read the article

The Alzheimer’s Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study.

22 August, 2024

medRxiv . 2024 Aug 22:2024.08.22.24312244. doi: 10.1101/2024.08.22.24312244. PMID: 39228740 Free PMC article. Preprint.

Read the article

Disentangling genetic risks for development and progression of Alzheimer’s disease.

1 August, 2024

Brain. 2024 Aug 1;147(8):2604-2606. doi: 10.1093/brain/awae237.PMID: 39018494 Free PMC article.

Read the article

The CentiMarker Project: Standardizing Quantitative Alzheimer’s disease Fluid Biomarkers for Biologic Interpretation

29 July, 2024

medRxiv . 2024 Jul 27:2024.07.25.24311002. doi: 10.1101/2024.07.25.24311002.PMID: 39108526 Free PMC article. Preprint.

Read the article

Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment

28 July, 2024

JAMA Neurol. 2024 Jul 28:e242619. doi: 10.1001/jamaneurol.2024.2619. Online ahead of print.PMID: 39068669 Free PMC article.

Read the article

MRI Signature of α-Synuclein Pathology in Asymptomatic Stages and a Memory Clinic Population

JAMA Neurol. 2024 Jul 28:e242713. doi: 10.1001/jamaneurol.2024.2713. Online ahead of print.PMID: 39068668

Read the article

Harmonizing tau positron emission tomography in Alzheimer’s disease: The CenTauR scale and the joint propagation model

23 July, 2024

Alzheimers Dement. 2024 Jul 23. doi: 10.1002/alz.13908. Online ahead of print.PMID: 39041435

Read the article

A clinical perspective on the revised criteria for diagnosis and staging of Alzheimer’s disease

20 July, 2024

Nat Aging. 2024 Aug;4(8):1029-1031. doi: 10.1038/s43587-024-00675-3.PMID: 39009837. No abstract available.

Read the article

Clinical recognition of frontotemporal dementia with right anterior temporal predominance: A multicenter retrospective cohort study

10 July, 2024

Alzheimers Dement. 2024 Jul 10. doi: 10.1002/alz.14076. Online ahead of print.PMID: 38982845

Read the article

Divergent functional connectivity changes associated with white matter hyperintensities

Neuroimage. 2024 Aug 1;296:120672. doi: 10.1016/j.neuroimage.2024.120672. Epub 2024 Jun 6.PMID: 38851551 Free article.

Read the article

Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity

9 July, 2024

Neurology. 2024 Jul 9;103(1):e209419. doi: 10.1212/WNL.0000000000209419. Epub 2024 Jun 11.PMID: 38862136 Free PMC article.

Read the article

Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer’s disease

6 July, 2024

Alzheimers Res Ther. 2024 Jul 6;16(1):154. doi: 10.1186/s13195-024-01521-9.PMID: 38971815 Free PMC article.

Read the article

A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings

5 July, 2024

Brain. 2024 Jul 5;147(7):2400-2413. doi: 10.1093/brain/awae118.PMID: 38654513 Free PMC article.

Read the article

A Comprehensive Head-to-Head Comparison of Key Plasma Phosphorylated Tau 217 Biomarker Tests

medRxiv . 2024 Jul 5:2024.07.02.24309629. doi: 10.1101/2024.07.02.24309629.PMID: 39006421 Free PMC article.

Read the article

Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patterns

Alzheimers Res Ther. 2024 Jul 5;16(1):153. doi: 10.1186/s13195-024-01517-5.PMID: 38970077  Free PMC article.

Read the article

Acceptable performance of blood biomarker tests of amyloid pathology – recommendations from the Global CEO Initiative on Alzheimer’s Disease

1 July, 2024

Nat Rev Neurol. 2024 Jul;20(7):426-439. doi: 10.1038/s41582-024-00977-5. Epub 2024 Jun 12.PMID: 38866966 Review.

Read the article

Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup

27 June, 2024

Alzheimers Dement. 2024 Jun 27. doi: 10.1002/alz.13859. Online ahead of print.PMID: 38934362

Read the article

Associations of modifiable and non-modifiable risk factors with cognitive functions – a prospective, population-based, 17 years follow-up study of 3,229 individuals

26 June, 2024

Alzheimers Res Ther. 2024 Jun 26;16(1):135. doi: 10.1186/s13195-024-01497-6.PMID: 38926747  Free PMC article.

Read the article

Effects of time of the day at sampling on CSF and plasma levels of Alzheimer’ disease biomarkers

22 June, 2024

Alzheimers Res Ther. 2024 Jun 22;16(1):132. doi: 10.1186/s13195-024-01503-x.PMID: 38909218  Free PMC article.

Read the article

In vivo detection of Alzheimer’s and Lewy body disease concurrence: Clinical implications and future perspectives

21 June, 2024

Alzheimers Dement. 2024 Jun 21. doi: 10.1002/alz.14039. Online ahead of print.PMID: 38955137 Review.

Read the article

Structural and functional connectivity associations with anterior cingulate sulcal variability

20 June, 2024

Brain Struct Funct. 2024 Jun 20. doi: 10.1007/s00429-024-02812-5. Online ahead of print.PMID: 38900167

Read the article

Head-to-Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders: An International, Multicenter Study

18 June, 2024

Ann Neurol. 2024 Jun 18. doi: 10.1002/ana.27008. Online ahead of print.PMID: 38888212

Read the article

MRI-Derived AD Signature of Cortical Thinning and Plasma P-Tau217 for Predicting Alzheimer Dementia Among Community-Dwelling Older Adults

15 June, 2024

Neurol Clin Pract. 2024 Jun;14(3):e200291. doi: 10.1212/CPJ.0000000000200291. Epub 2024 Apr 15.PMID: 38720951

Read the article

Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathology

13 June, 2024

medRxiv . 2024 Jun 13:2024.06.12.24308824. doi: 10.1101/2024.06.12.24308824.PMID: 38947004 Free PMC article. Preprint.

Read the article

Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer’s disease

12 June, 2024

Alzheimers Dement. 2024 Jun 12. doi: 10.1002/alz.13919. Online ahead of print.PMID: 38867417

Read the article

Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment

10 June, 2024

JAMA Neurol. 2024 Jun 10:e241612. doi: 10.1001/jamaneurol.2024.1612. Online ahead of print.PMID: 38857029 Free PMC article.

Read the article

Identification of distinct and shared biomarker panels in different manifestations of cerebral small vessel disease through proteomic profiling

medRxiv . 2024 Jun 10:2024.06.10.24308599. doi: 10.1101/2024.06.10.24308599.PMID: 38947084 Free PMC article. Preprint.

Read the article

A machine learning-based prediction of tau load and distribution in Alzheimer’s disease using plasma, MRI and clinical variables

31 May, 2024

medRxiv . 2024 May 31:2024.05.31.24308264. doi: 10.1101/2024.05.31.24308264.PMID: 38853877 Free PMC article. Preprint.

Read the article

Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly

23 May, 2024

Alzheimers Res Ther. 2024 May 23;16(1):115. doi: 10.1186/s13195-024-01469-w.PMID: 38778353  Free PMC article.

Read the article

Medial temporal lobe atrophy patterns in early- versus late-onset amnestic Alzheimer’s disease

21 May, 2024

bioRxiv . 2024 May 21:2024.05.21.594976. doi: 10.1101/2024.05.21.594976.PMID: 38826333 Free PMC article. Preprint.

Read the article

Plasma p-tau217 in Alzheimer’s disease: Lumipulse and ALZpath SIMOA head-to-head comparison

3 May, 2024

medRxiv . 2024 May 3:2024.05.02.24306780. doi: 10.1101/2024.05.02.24306780.PMID: 38746261 Free PMC article. Preprint.

Read the article

Fixel-Based Analysis Reveals Tau-Related White Matter Changes in Early Stages of Alzheimer’s Disease

1 May, 2024

J Neurosci. 2024 May 1;44(18):e0538232024. doi: 10.1523/JNEUROSCI.0538-23.2024.PMID: 38565289  Free PMC article.

Read the article

Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases

Nat Commun. 2024 May 1;15(1):3676. doi: 10.1038/s41467-024-47971-5.PMID: 38693142 Free PMC article.

Read the article

Biomarker-based staging of Alzheimer disease: rationale and clinical applications

20 April, 2024

Nat Rev Neurol. 2024 Apr;20(4):232-244. doi: 10.1038/s41582-024-00942-2. Epub 2024 Mar 1.PMID: 38429551 Review.

Read the article

Plasma glial fibrillary acidic protein and tau: predictors of neurological outcome after cardiac arrest

9 April, 2024

Crit Care. 2024 Apr 9;28(1):116. doi: 10.1186/s13054-024-04889-0.PMID: 38594704 Free PMC article.

Read the article

Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia

8 April, 2024

medRxiv . 2024 Apr 8:2024.04.07.24305362. doi: 10.1101/2024.04.07.24305362.PMID: 38645076 Free PMC article. Preprint.

Read the article

Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.

28 March, 2024

Res Sq . 2024 Mar 28:rs.3.rs-4103685. doi: 10.21203/rs.3.rs-4103685/v1.PMID: 38585969 Free PMC article. Preprint.

Read the article

Altered empathy processing in frontotemporal dementia A task-based fMRI study

26 March, 2024

bioRxiv . 2024 Mar 26:2024.03.21.586051. doi: 10.1101/2024.03.21.586051.PMID: 38585830  Free PMC article. Preprint.

Read the article

Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer’s disease in patients with mild cognitive symptoms

19 March, 2024

Alzheimers Res Ther. 2024 Mar 19;16(1):61. doi: 10.1186/s13195-024-01428-5.PMID: 38504336 Free PMC article.

Read the article

Is GBA1 T369M not a risk factor for Parkinson’s disease in the Swedish population?

16 March, 2024

medRxiv . 2024 Mar 16:2024.03.15.24304347. doi: 10.1101/2024.03.15.24304347.PMID: 38559109 Free PMC article. Preprint.

Read the article

A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings

14 March, 2024

Nat Commun. 2024 Mar 14;15(1):2311. doi: 10.1038/s41467-024-46603-2.PMID: 38486040 Free PMC article.

Read the article

Diffusion MRI tracks cortical microstructural changes during the early stages of Alzheimer’s disease.

1 March, 2024

Brain. 2024 Mar 1;147(3):961-969. doi: 10.1093/brain/awad428.PMID: 38128551 Free PMC article.

Read the article

Interactions between vascular burden and amyloid-β pathology on trajectories of tau accumulation.

Brain. 2024 Mar 1;147(3):949-960. doi: 10.1093/brain/awad317.PMID: 37721482 Free PMC article

Read the article

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease.

17 February, 2024

Mol Neurodegener. 2024 Feb 17;19(1):19. doi: 10.1186/s13024-024-00707-x.PMID: 38365825 Free PMC article.

Read the article

Prognostic and Predictive Factors in Early Alzheimer’s Disease: A Systematic Review.

16 February, 2024

J Alzheimers Dis Rep. 2024 Feb 16;8(1):203-240. doi: 10.3233/ADR-230045. eCollection 2024.PMID: 38405341 Free PMC article.

Read the article

Putaminal T1/T2-weighted ratio is increased in PSP compared to PD and healthy controls, a multi-cohort study.

13 February, 2024

Parkinsonism Relat Disord. 2024 Feb 13;121:106047. doi: 10.1016/j.parkreldis.2024.106047. Online ahead of print.PMID: 38368753 Free article.

Read the article

The Relationship between p-tau217, p-tau231, and p-tau205 in the Human Brain Is Affected by the Cellular Environment and Alzheimer’s Disease Pathology.

11 February, 2024

Cells. 2024 Feb 11;13(4):331. doi: 10.3390/cells13040331.PMID: 38391945 Free PMC article.

Read the article

Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis.

Lancet Neurol. 2024 Feb;23(2):168-177. doi: 10.1016/S1474-4422(23)00414-3.PMID: 38267189 Free article.

Read the article

Effects of certain pre-analytical factors on the performance of plasma phospho-tau217.

8 February, 2024

Alzheimers Res Ther. 2024 Feb 8;16(1):31. doi: 10.1186/s13195-024-01391-1.PMID: 38331843 Free PMC article.

Read the article

Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease.

Ann Neurol. 2024 Feb;95(2):274-287. doi: 10.1002/ana.26818. Epub 2023 Oct 25.PMID: 37837382

Read the article

Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases.

7 February, 2024

Brain. 2024 Feb 7:awae032. doi: 10.1093/brain/awae032. Online ahead of print.PMID: 38325331

Read the article

Diffusion weighted magnetic resonance spectroscopy revealed neuronal specific microstructural alterations in Alzheimer’s disease.

1 February, 2024

Brain Commun. 2024 Feb 1;6(1):fcae026. doi: 10.1093/braincomms/fcae026. eCollection 2024.PMID: 38370447 Free PMC article.

Read the article

Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology.

7 January, 2024

Mol Neurodegener. 2024 Jan 7;19(1):2. doi: 10.1186/s13024-023-00689-2.PMID: 38185677 Free PMC article.

Read the article

The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer’s disease patients and AppNL-F/NL-F mice.

2 January, 2024

M.Alzheimers Res Ther. 2024 Jan 2;16(1):4. doi: 10.1186/s13195-023-01375-7.PMID: 38167557 Free PMC article.

Read the article

Harnessing cognitive trajectory clusterings to examine subclinical decline risk factors.

3 December, 2023

Brain Commun. 2023 Dec 3;5(6):fcad333. doi: 10.1093/braincomms/fcad333. eCollection 2023.PMID: 38107504 Free PMC article.

Read the article

The molecular genetic landscape of human brain size variation.

28 November, 2023

Cell Rep. 2023 Nov 28;42(11):113439. doi: 10.1016/j.celrep.2023.113439. Epub 2023 Nov 14.PMID: 37963017 Free article.

Read the article

Effects of Brain Pathologies on Spatiotemporal Gait Parameters in Patients with Mild Cognitive Impairment.

31 October, 2023

J Alzheimers Dis. 2023;96(1):161-171. doi: 10.3233/JAD-221303.PMID: 37742636 Free PMC article.

Read the article

Cognitive effects of Lewy body pathology in clinically unimpaired individuals.

14 September, 2023

Nat Med. 2023 Aug;29(8):1971-1978. doi: 10.1038/s41591-023-02450-0.

Read the article

Clinical effects of Lewy body pathology in cognitively impaired individuals.

Nat Med. 2023 Aug;29(8):1964-1970. doi: 10.1038/s41591-023-02449-7.

Read the article

CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease.

Nat Med. 2023 Aug;29(8):1954-1963. doi: 10.1038/s41591-023-02443-z.

Read the article

Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring.

Nat Med. 2022 Dec;28(12):2555-2562. doi: 10.1038/s41591-022-02074-w.

Read the article

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline.

Nat Med. 2022 Nov;28(11):2381-2387. doi: 10.1038/s41591-022-02049-x.

Read the article

Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer’s disease pathology.

11 September, 2023

Nat Aging. 2022 Dec;2(12):1138-1144. doi: 10.1038/s43587-022-00310-z.

Read the article

Associations of CSF PDGFRβ With Aging, Blood-Brain Barrier Damage, Neuroinflammation, and Alzheimer Disease Pathologic Changes.

Neurology. 2023 Jul 4;101(1):e30-e39. doi: 10.1212/WNL.0000000000207358.

Read the article

Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.

Alzheimer’s Disease Neuroimaging Initiative. JAMA Neurol. 2023 Jun 1;80(6):614-623. doi: 10.1001/jamaneurol.2023.1067.

Read the article

Higher plasma β-synuclein indicates early synaptic degeneration in Alzheimer’s disease.

Alzheimers Dement. 2023 Apr 27. doi: 10.1002/alz.13103

Read the article

Clinical Utility of Tau Positron Emission Tomography in the Diagnostic Workup of Patients With Cognitive Symptoms.

JAMA Neurol. 2023 Jul 1;80(7):749-756. doi: 10.1001/jamaneurol.2023.1323.

Read the article

Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders.

Aust N Z J Psychiatry. 2023 Jul 21:48674231187312. doi: 10.1177/00048674231187312.

Read the article

Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.

Nat Immunol. 2023 Sep;24(9):1540-1551. doi: 10.1038/s41590-023-01588-w.

Read the article

Direct Conversion of Fibroblast into Neurons for Alzheimer’s Disease Research: A Systematic Review

25 August, 2023

J Alzheimers Dis. 2023;95(3):805-828. doi: 10.3233/JAD-230119.PMID: 37661882 Free PMC article.

Read the article

Blood biomarkers for Alzheimer’s disease in clinical practice and trials.

11 August, 2023

Nat Aging. 2023 May;3(5):506-519. doi: 10.1038/s43587-023-00403-3

Read the article

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease.

12 June, 2023

Nat Aging. 2023 Apr;3(4):391-401. doi: 10.1038/s43587-023-00380-7.

Read the article

Age-related and amyloid-beta-independent tau deposition and its downstream effects.

Brain. 2023 Aug 1;146(8):3192-3205. doi: 10.1093/brain/awad135.

Read the article

Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the AppNL-F/NL-F knock-in mouse model of Alzheimer’s disease.

Alzheimers Res Ther. 2023 Mar 25;15(1):64. doi: 10.1186/s13195-023-01196-8.

Read the article

Plasma amyloid-β42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer’s disease.

Brain Commun. 2023 Jan 24;5(2):fcad015. doi: 10.1093/braincomms/fcad015. eCollection 2023.

Read the article

Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia.

Neurology. 2023 Apr 25;100(17):e1812-e1824. doi: 10.1212/WNL.0000000000207113.

Read the article

Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers.

JAMA Neurol. 2023 Apr 1;80(4):360-369. doi: 10.1001/jamaneurol.2022.5272.

Read the article

Discriminative accuracy of the A/T/N scheme to identify cognitive impairment due to Alzheimer’s disease.

Alzheimers Dement (Amst). 2023 Jan 30;15(1):e12390. doi: 10.1002/dad2.12390.

Read the article

Robustness of CSF Aβ42/40 and Aβ42/P-tau181 measured using fully automated immunoassays to detect AD-related outcomes.

O. Alzheimers Dement. 2023 Jul;19(7):2994-3004. doi: 10.1002/alz.12897.

Read the article

Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A multi-cohort study.

Alzheimers Dement. 2023 Jul;19(7):2943-2955. doi: 10.1002/alz.12907.

Read the article

Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients.

Alzheimers Dement. 2023 Jun;19(6):2497-2507. doi: 10.1002/alz.12875.

Read the article

Novel insights regarding the measurement properties of the SCOPA-AUT.

BMC Neurol. 2022 Dec 13;22(1):478. doi: 10.1186/s12883-022-03008-2.

Read the article

[18F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes.

Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1371-1383. doi: 10.1007/s00259-022-06065-4.

Read the article

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum.

Mol Neurodegener. 2022 Dec 12;17(1):81. doi: 10.1186/s13024-022-00586-0.

Read the article

The genetic regulation of protein expression in cerebrospinal fluid.

EMBO Mol Med. 2023 Jan 11;15(1):e16359. doi: 10.15252/emmm.202216359.

Read the article

Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson’s Disease and Related Disorders.

Mov Disord. 2023 Feb;38(2):267-277. doi: 10.1002/mds.29287.

Read the article

Performance of [18F]RO948 PET, MRI and CSF neurofilament light in the differential diagnosis of progressive supranuclear palsy.

Parkinsonism Relat Disord. 2023 Jan;106:105226. doi: 10.1016/j.parkreldis.2022.11.018.

Read the article

Gray matter hypoperfusion is a late pathological event in the course of Alzheimer’s disease.

J Cereb Blood Flow Metab. 2023 Apr;43(4):565-580. doi: 10.1177/0271678X221141139.

Read the article

CSF ferritin in the clinicopathological progression of Alzheimer’s disease and associations with APOE and inflammation biomarkers.

J Neurol Neurosurg Psychiatry. 2023 Mar;94(3):211-219. doi: 10.1136/jnnp-2022-330052.

Read the article

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease.

Nat Commun. 2022 Nov 4;13(1):6635. doi: 10.1038/s41467-022-34129-4.

Read the article

Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease.

Clin Chem Lab Med. 2022 Oct 24;61(2):234-244. doi: 10.1515/cclm-2022-0516.

Read the article

Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy.

Alzheimers Res Ther. 2022 Oct 4;14(1):144. doi: 10.1186/s13195-022-01081-w.

Read the article

Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease.

Alzheimers Res Ther. 2022 Sep 24;14(1):139. doi: 10.1186/s13195-022-01074-9.

Read the article

Confounding factors of Alzheimer’s disease plasma biomarkers and their impact on clinical performance.

Alzheimers Dement. 2023 Apr;19(4):1403-1414. doi: 10.1002/alz.12787.

Read the article

Clinical performance and robustness evaluation of plasma amyloid-β42/40prescreening.

Alzheimers Dement. 2023 Apr;19(4):1393-1402. doi: 10.1002/alz.12801.

Read the article

Measures of cortical microstructure are linked to amyloid pathology in Alzheimer’s disease.

Brain. 2023 Apr 19;146(4):1602-1614. doi: 10.1093/brain/awac343.

Read the article

Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease.

Brain. 2023 Apr 19;146(4):1592-1601. doi: 10.1093/brain/awac333.

Read the article

Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals.

Brain. 2023 Apr 19;146(4):1580-1591. doi: 10.1093/brain/awac329.

Read the article

Anterior cingulate sulcation is associated with onset and survival in frontotemporal dementia.

medRxiv. 2023 Mar 31:2023.03.30.23287945. doi: 10.1101/2023.03.30.23287945.

Read the article

Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios.

JAMA Neurol. 2023 May 1;80(5):516-522. doi: 10.1001/jamaneurol.2023.0199.

Read the article

The emerging era of staging Alzheimer’s disease pathology using plasma biomarkers

2 May, 2023

Brain. 2023 May 2;146(5):1740-1742. doi: 10.1093/brain/awad112.PMID: 37019849

Read the article

Plasma neurofilament light is a predictor of neurological outcome 12 h after cardiac arrest

24 February, 2023

Crit Care. 2023 Feb 24;27(1):74. doi: 10.1186/s13054-023-04355-3.PMID: 36829239 Free PMC article.

Read the article

Spatial Navigation and Its Association With Biomarkers and Future Dementia in Memory Clinic Patients Without Dementia.

17 June, 2022

Neurology. 2022 Nov 8;99(19):e2081-e2091. doi: 10.1212/WNL.0000000000201106.

Read the article

Earlier Alzheimer’s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading.

Nat Commun. 2022 Aug 20;13(1):4899. doi: 10.1038/s41467-022-32592-7.

Read the article

An accurate fully automated panel of plasma biomarkers for Alzheimer’s disease.

Alzheimers Dement. 2023 Apr;19(4):1204-1215. doi: 10.1002/alz.12751.

Read the article

Clinically Relevant Changes for Cognitive Outcomes in Preclinical and Prodromal Cognitive Stages: Implications for Clinical Alzheimer Trials.

Neurology. 2022 Sep 13;99(11):e1142-e1153. doi: 10.1212/WNL.0000000000200817.

Read the article

Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease.

Acta Neuropathol Commun. 2022 Jun 22;10(1):90. doi: 10.1186/s40478-022-01388-7.

Read the article

Astrocytic function is associated with both amyloid-β and tau pathology in non-demented APOE ϵ4 carriers.

Brain Commun. 2022 May 22;4(3):fcac135. doi: 10.1093/braincomms/fcac135.

Read the article

Test-retest variability of plasma biomarkers in Alzheimer’s disease and its effects on clinical prediction models.

Alzheimers Dement. 2022 Jun 14:10.1002/alz.12706. doi: 10.1002/alz.12706.

Read the article

β-Amyloid-Dependent and -Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease.

Neurology. 2022 May 31;99(5):e476-87. doi: 10.1212/WNL.0000000000200605.

Read the article

Diagnostic and prognostic performance to detect Alzheimer’s disease and clinical progression of a novel assay for plasma p-tau217.

Alzheimers Res Ther. 2022 May 14;14(1):67. doi: 10.1186/s13195-022-01005-8.

Read the article

Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer’s dementia in mild cognitive impairment patients.

Alzheimers Res Ther. 2022 Mar 29;14(1):46. doi: 10.1186/s13195-022-00990-0.

Read the article

Development of Apathy, Anxiety, and Depression in Cognitively Unimpaired Older Adults: Effects of Alzheimer’s Disease Pathology and Cognitive Decline.

Biol Psychiatry. 2022 Jan 31:S0006-3223(22)00053-1. doi: 10.1016/j.biopsych.2022.01.012.

Read the article

Midsagittal corpus callosal thickness and cognitive impairment in Parkinson’s disease.

Eur J Neurosci. 2022 Apr;55(7):1859-1872. doi: 10.1111/ejn.15640.

Read the article

Subtypes of Alzheimer’s disease: questions, controversy, and meaning.

Trends Neurosci. 2022 May;45(5):342-345. doi: 10.1016/j.tins.2022.02.001.

Read the article

Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration.

Neurology. 2022 Mar 15;98(11):e1137-e1150. doi: 10.1212/WNL.0000000000200040.

Read the article

The Neuroinflammatory Acute Phase Response in Parkinsonian-Related Disorders.

Mov Disord. 2022 Feb 8. doi: 10.1002/mds.28958.

Read the article

Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer’s disease and frontotemporal disorders in clinical settings.

Alzheimers Dement. 2022 Feb 1. doi: 10.1002/alz.12549.

Read the article

Components of gait in people with and without mild cognitive impairment.

Gait Posture. 2022 Mar;93:83-89. doi: 10.1016/j.gaitpost.2022.01.012.

Read the article

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.

JAMA Neurol. 2022 Mar 1;79(3):228-243. doi: 10.1001/jamaneurol.2021.5216.

Read the article

Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.

JAMA Neurol. 2022 Feb 1;79(2):149-158. doi: 10.1001/jamaneurol.2021.4654.

Read the article

Blood-based biomarkers for Alzheimer’s disease.

EMBO Mol Med. 2022 Jan 11;14(1):e14408. doi: 10.15252/emmm.202114408.

Read the article

Blood-based biomarkers for Alzheimer’s disease: towards clinical implementation.

Lancet Neurol. 2022 Jan;21(1):66-77. doi: 10.1016/S1474-4422(21)00361-6.

Read the article

Serum Neurofilament Light Chain as a Marker of Progression in Parkinson’s Disease: Long-Term Observation and Implications of Clinical Subtypes.

J Parkinsons Dis. 2022;12(2):571-584. doi: 10.3233/JPD-212866.

Read the article

Connecting Cohorts to Diminish Alzheimer’s Disease (CONCORD-AD): A Report of an International Research Collaboration Network.

J Alzheimers Dis. 2022;85(1):31-45. doi: 10.3233/JAD-210525.

Read the article

Insights on Genetic and Environmental Factors in Parkinson’s Disease from a Regional Swedish Case-Control Cohort.

J Parkinsons Dis. 2022;12(1):153-171. doi: 10.3233/JPD-212818.

Read the article

Detecting amyloid positivity in early Alzheimer’s disease using combinations of plasma Aβ42/Aβ40 and p-tau.

Alzheimers Dement. 2022 Feb;18(2):283-293. doi: 10.1002/alz.12395.

Read the article

Decreased pain sensitivity and alterations of cerebrospinal fluid and plasma inflammatory mediators after total hip arthroplasty in patients with disabling osteoarthritis.

Pain Pract. 2022 Jan;22(1):66-82. doi: 10.1111/papr.13051.

Read the article

The BIN1 rs744373 Alzheimer’s disease risk SNP is associated with faster Aβ-associated tau accumulation and cognitive decline.

Alzheimers Dement. 2022 Jan;18(1):103-115. doi: 10.1002/alz.12371.

Read the article

Prenatal Gyrification Pattern Affects Age at Onset in Frontotemporal Dementia.

Santillo A.Cereb Cortex. 2022 Jan 17:bhab457. doi: 10.1093/cercor/bhab457.

Read the article

Association of β-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition.

Alzheimer’s Disease Neuroimaging Initiative.Neurology. 2022 Jan 12:10.1212/WNL.0000000000013299. doi: 10.1212/WNL.0000000000013299.

Read the article

Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels.

Acta Neuropathol Commun. 2022 Jan 6;10(1):3. doi: 10.1186/s40478-021-01307-2.

Read the article

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias.

3 February, 2022

Abstract Background: Elevated cerebrospinal fluid (CSF) concentrations of total tau (T-tau) and phosphorylated tau at Thr181 (P-tau181) protein are typical of Alzheimer’s disease (AD). However, the T-tau assay measures only the mid-region of the protein, while tau in CSF is instead composed of a series of fragments. One fragment species in particular, N-224, shows increased levels

Read the article

Structural and functional neuroimaging changes associated with cognitive impairment and dementia in Parkinson’s disease.

30 June, 2021

Abstract This study seeks a better understanding of possible pathophysiological mechanisms associated with cognitive impairment and dementia in Parkinson’s disease using structural and functional MRI. We investigated resting-state functional connectivity of important subdivisions of the caudate nucleus, putamen and thalamus, and also how the morphology of these structures are impacted in the disorder. We found

Read the article

Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures

24 June, 2021

Abstract A combination of plasma phospho-tau (P-tau) and other accessible biomarkers might provide accurate prediction about the risk of developing Alzheimer’s disease (AD) dementia. We examined this in participants with subjective cognitive decline and mild cognitive impairment from the BioFINDER (n = 340) and Alzheimer’s Disease Neuroimaging Initiative (ADNI) (n = 543) studies. Plasma P-tau,

Read the article

Association of CSF Aβ38 Levels With Risk of Alzheimer Disease-Related Decline.

14 June, 2021

Neurology. 2021 Dec 22:10.1212/WNL.0000000000013228. doi: 10.1212/WNL.0000000000013228. PMID: 34937781

Read the article

Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.

JAMA Neurol. 2021 Dec 20:e214654. doi: 10.1001/jamaneurol.2021.4654..PMID: 34928318 Free PMC article.

Read the article

Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques.

Neurology. 2021 Dec 14:10.1212/WNL.0000000000013211. doi: 10.1212/WNL.0000000000013211..PMID: 34906975

Read the article

The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individuals.

ALFA study†, BioFINDER, ADNI.Alzheimers Dement. 2021 Dec 8. doi: 10.1002/alz.12487.

Read the article

Characterization of pre-analytical sample handling effects on a panel of Alzheimer’s disease-related blood-based biomarkers: Results from the Standardization of Alzheimer’s Blood Biomarkers (SABB) working group.

Read the article

Connecting Cohorts to Diminish Alzheimer’s Disease (CONCORD-AD): A Report of an International Research Collaboration Network.

CONCORD-AD investigators.J Alzheimers Dis. 2022;85(1):31-45. doi: 10.3233/JAD-210525.

Read the article

The global Alzheimer’s Association round robin study on plasma amyloid β methods.

Alzheimers Dement (Amst). 2021 Oct 14;13(1):e12242. doi: 10.1002/dad2.12242. eCollection 2021.

Read the article

Genetic effects on longitudinal cognitive decline during the early stages of Alzheimer’s disease.

Sci Rep. 2021 Oct 6;11(1):19853. doi: 10.1038/s41598-021-99310-z.

Read the article

Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease.

JAMA Neurol. 2021 Nov 1;78(11):1375-1382. doi: 10.1001/jamaneurol.2021.3180.

Read the article

Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays.

Neurology. 2021 Oct 26;97(17):e1681-e1694. doi: 10.1212/WNL.0000000000012727. Epub 2021 Sep 7.

Read the article